Back to home
DXCM logo

Is DXCM (DexCom, Inc.) Halal or Haram?

NASDAQ Global SelectHealthcareMedical - Devices$22.89B2026-04-29
DXCM is Halal4/4 screens passed

DexCom easily passes all AAOIFI shariah screening criteria, making it a fully compliant investment. The company operates with a very conservative capital structure, carrying a debt-to-market cap ratio of just 6.1%, well below the 33% threshold. Furthermore, its interest income is negligible at 0.00% of revenue, ensuring investors are not exposed to impermissible financial gains.

Price Chart (5D)

$61.33+0.67 (+1.10%)
2026-05-012026-04-24

DXCM — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-05-0160.9962.8559.7061.3510.6M+0.59%
2026-04-3057.8859.6457.5859.555.3M+2.89%
2026-04-2958.9558.9556.7257.566.6M-2.36%
2026-04-2861.6862.4459.0959.325.6M-3.83%
2026-04-2761.1262.0861.0461.413.4M+0.47%
2026-04-2462.6762.9060.3461.573.6M-1.76%
2026-04-2363.0963.7861.9062.702.5M-0.62%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for DXCM

Business Activity

Permissible

DexCom's core business of developing continuous glucose monitoring systems like the DexCom G6 for diabetes management is entirely permissible and aligns with Islamic principles of preserving health.

Debt / Market Cap

6.07%

Debt: $1.39BThreshold: ≤33%

Interest Income

0.00%

Interest: $0Threshold: ≤5%

Cash & Securities

8.73%

Cash: $2.00BThreshold: ≤33%

About DexCom, Inc. (DXCM)

DexCom, Inc. is a leading medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Their flagship products, including the DexCom G6 and Dexcom ONE, eliminate the need for traditional finger-stick blood tests, significantly improving the quality of life for patients globally.

For Muslim investors, DexCom represents a strong Halal investment opportunity as it successfully passes all four AAOIFI shariah screens. The company's core business of healthcare technology is inherently permissible, and its financial structure strictly adheres to Islamic finance guidelines, meaning investors can confidently add this stock to their halal portfolios.

From an Islamic finance perspective, DexCom's financial health is exceptionally robust. The company maintains very low leverage with a debt-to-market cap ratio of just 6.1%, and its cash and securities sit comfortably at 8.7% of its market capitalization. Notably, it generates zero non-compliant interest income, keeping its revenue stream pure.

Because the medical device industry is generally free of shariah controversies, there is no significant scholarly debate regarding DexCom's core operations. However, halal investors should continue to monitor its quarterly financial reports to ensure its debt levels remain well below the 33% threshold as the company expands internationally.

CEO

Jacob Steven Leach

Employees

10,200

IPO Date

2005-04-14

Headquarters

San Diego, CA, US

DXCM Key Financial Statistics

Revenue

$4.66B

Net Income

$836.3M

EPS (Diluted)

$2.09

Stock Price

59.32

Beta

1.56

52-Week Range

54.11-89.98

Total Debt

$1.39B

Total Equity

$2.75B

Current Ratio

1.88

DXCM Financial Health & Profitability

Profit Margins

Gross Margin60.1%
Operating Margin19.6%
Net Margin17.9%

Revenue Growth (YoY)

+15.6%

Prior year: $4.03B

Net Debt

$472.0M

Cash: $917.7M — Debt: $1.39B

R&D Spending

$599.1M

% of Revenue

12.9%

Frequently Asked Questions About DXCM

Is DXCM (DexCom, Inc.) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, DXCM is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (6.07% vs ≤33% threshold), interest income ratio (0.00% vs ≤5% threshold), and cash & securities ratio (8.73% vs ≤33% threshold).
What does DexCom, Inc. do?
DexCom, Inc. is a leading medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Their flagship products, including the DexCom G6 and Dexcom ONE, eliminate the need for traditional finger-stick blood tests, significantly improving the quality of life for patients globally. For Muslim investors, DexCom represents a strong Halal investment opportunity as it successfully passes all four AAOIFI shariah screens. The company's core business of healthcare technology is inherently permissible, and its financial structure strictly adheres to Islamic finance guidelines, meaning investors can confidently add this stock to their halal portfolios. From an Islamic finance perspective, DexCom's financial health is exceptionally robust. The company maintains very low leverage with a debt-to-market cap ratio of just 6.1%, and its cash and securities sit comfortably at 8.7% of its market capitalization. Notably, it generates zero non-compliant interest income, keeping its revenue stream pure. Because the medical device industry is generally free of shariah controversies, there is no significant scholarly debate regarding DexCom's core operations. However, halal investors should continue to monitor its quarterly financial reports to ensure its debt levels remain well below the 33% threshold as the company expands internationally. DexCom, Inc. operates in the Healthcare sector under the Medical - Devices industry and is headquartered in San Diego, CA, US. The company is led by CEO Jacob Steven Leach and employs approximately 10,200 people.
What screening criteria were used for DXCM?
DXCM was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. DXCM passed 4 of these 4 screens.
Does DXCM require income purification?
DXCM has negligible interest income, so purification may not be necessary. However, it is always advisable to consult a qualified scholar regarding your specific investment situation.
When was DXCM last screened?
DXCM was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for DXCM (DexCom, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.

Other Halal Stocks in Healthcare